• 1844 Citations
  • 18 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1844 Citations
  • 18 h-Index
  • 34 Article
  • 2 Chapter
2020
Open Access

Performance Characteristics of a Real-Time Polymerase Chain Reaction Assay for the Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Plasma Samples of Non-Small Cell Lung Cancer (NSCLC) Patients

O’Donnell, P., May, T., DeMartin, K., Ferguson, J., Halait, H., Wei, W., Yu, K. & Scudder, S., Jan 1 2020, (Accepted/In press) In : Molecular Diagnosis and Therapy.

Research output: Contribution to journalArticle

2019

Osimertinib (TAGRISSO™) and the cobas® EGFR Mutation Test v2

Jenkins, S., Cross, D. & Scudder, S. A., Jan 1 2019, Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation. Elsevier, p. 429-443 15 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Polymerase chain reaction

Yu, K., Karwowska, S., Sharma, A., Liesenfeld, O. & Scudder, S. A., Jan 1 2019, Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation. Elsevier, p. 111-133 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2018

Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies

on behalf of the ENSURE FASTACT-2 and ASPIRATION Investigators, Dec 1 2018, In : Lung Cancer. 126, p. 1-8 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

Keppens, C., Palma, J. F., Das, P. M., Scudder, S. A., Wen, W., Normanno, N., van Krieken, J. H., Sacco, A., Fenizia, F., Gonzalez de Castro, D., Hönigschnabl, S., Kern, I., Lopez-Rios, F., Lozano, M. D., Marchetti, A., Halfon, P., Schuuring, E., Setinek, U., Sorensen, B., Taniere, P. & 3 others, Tiemann, M., Vosmikova, H. & Dequeker, E. M. C., Jul 1 2018, In : Journal of Molecular Diagnostics. 20, 4, p. 483-494 12 p.

Research output: Contribution to journalArticle

13 Scopus citations
2017

The clinical and economic impact of inaccurate EGFR mutation tests in the treatment of metastatic non-small cell lung cancer

Cheng, M. M., Palma, J. F., Scudder, S. A., Poulios, N. & Liesenfeld, O., Sep 1 2017, In : Journal of Personalized Medicine. 7, 3, 5.

Research output: Contribution to journalArticle

8 Scopus citations
2014

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

Vergote, I., Schilder, R. J., Pippitt, C. H., Wong, S., Gordon, A. N., Scudder, S. A., Kridelka, F., Dirix, L., Leach, J. W., Ananda, S., Nanayakkara, N., Melara, R., Bass, M. B., Litten, J., Adewoye, H. & Wenham, R. M., Oct 1 2014, In : Gynecologic Oncology. 135, 1, p. 25-33 9 p.

Research output: Contribution to journalArticle

16 Scopus citations
2009
40 Scopus citations
2008

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

Garcia, A. A., Hirte, H., Fleming, G., Yang, D., Tsao-Wei, D. D., Roman, L., Groshen, S., Swenson, S., Markland, F., Gandara, D., Scudder, S., Morgan, R., Chen, H., Lenz, H. J. & Oza, A. M., Jan 1 2008, In : Journal of Clinical Oncology. 26, 1, p. 76-82 7 p.

Research output: Contribution to journalArticle

451 Scopus citations

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab

Schultheis, A. M., Lurje, G., Rhodes, K. E., Zhang, W., Yang, D., Garcia, A. A., Morgan, R., Gandara, D. R., Scudder, S. A., Oza, A., Hirte, H., Fleming, G., Roman, L. & Lenz, H. J., Nov 15 2008, In : Clinical Cancer Research. 14, 22, p. 7554-7563 10 p.

Research output: Contribution to journalArticle

152 Scopus citations
5 Scopus citations
2007

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: A California Cancer Consortium Trial

Morgan, R. J., Synold, T. W., Gandara, D. R., Muggia, F., Scudder, S. A., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M. & Doroshow, J. H., Mar 2007, In : International Journal of Gynecological Cancer. 17, 2, p. 373-378 6 p.

Research output: Contribution to journalArticle

5 Scopus citations
2006

Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients

Elliott, K. S., Borowsky, M. E., Malka, E. S., Scudder, S. A., Leiserowitz, G. S. & Russell, A. H., May 2006, In : Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 51, 5, p. 383-388 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
18 Scopus citations

Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: A Southwest Oncology Group study

Smith, H. O., Jiang, C. S., Weiss, G. R., Hallum, A. V., Liu, P. Y., Robinson, W. R., Cheng, P. C., Scudder, S. A., Markman, M. & Alberts, D. S., Jan 2006, In : International Journal of Gynecological Cancer. 16, 1, p. 298-305 8 p.

Research output: Contribution to journalArticle

21 Scopus citations
2005

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: A phase II study of the Southwest Oncology Group

Scudder, S. A., Liu, P. Y., Wilczynski, S. P., Smith, H. O., Jiang, C., Hallum, A. V., Smith, G. B., Hannigan, E. V., Markman, M. & Alberts, D. S., Mar 2005, In : Gynecologic Oncology. 96, 3, p. 610-615 6 p.

Research output: Contribution to journalArticle

42 Scopus citations
2004
26 Scopus citations

Chemoradiation for primary invasive squamous carcinoma of the vagina

Dalrymple, J. L., Russell, A. H., Lee, S. W., Scudder, S. A., Leiserowitz, G. S., Kinney, W. K. & Smith, L. H., Jan 2004, In : International Journal of Gynecological Cancer. 14, 1, p. 110-117 8 p.

Research output: Contribution to journalArticle

56 Scopus citations

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian

Morgan, R. J., Synold, T. W., Gandara, D., Muggia, F., Scudder, S., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M. & Doroshow, J. H., Oct 2004, In : Cancer Chemotherapy and Pharmacology. 54, 4, p. 283-289 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: A Southwest Oncology Group study

Stiff, P. J., Shpall, E. J., Liu, P. Y., Wilczynski, S. P., Callander, N. S., Scudder, S. A., Jazieh, A. R., Samlowski, W., McCoy, J. & Alberts, D. S., Jul 2004, In : Gynecologic Oncology. 94, 1, p. 98-106 9 p.

Research output: Contribution to journalArticle

14 Scopus citations
2003

Endometriosis-related malignancies

Leiserowitz, G. S., Gumbs, J. L., Oi, R., Dalrymple, J. L., Smith, L. H., Ryut, J., Scudder, S. A. & Russell, A. H., Jul 2003, In : International Journal of Gynecological Cancer. 13, 4, p. 466-471 6 p.

Research output: Contribution to journalArticle

62 Scopus citations

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

Wun, T., Law, L., Harvey, D. J., Sieracki, B., Scudder, S. A. & Ryu, J. K., Oct 1 2003, In : Cancer. 98, 7, p. 1514-1520 7 p.

Research output: Contribution to journalArticle

139 Scopus citations
2001
396 Scopus citations
1999
18 Scopus citations
1998

13-cis-retinoic acid or All-trans-retinoic acid plus interferon-α in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial

Weiss, G. R., Liu, P. Y., Alberts, D. S., Peng, Y. M., Fisher, E., Xu, M. J., Scudder, S. A., Baker, L. H., Moore, D. F. & Lippman, S. M., Dec 1998, In : Gynecologic Oncology. 71, 3, p. 386-390 5 p.

Research output: Contribution to journalArticle

35 Scopus citations

Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4)

Costa, M. J., Hansen, C., Dickerman, A. & Scudder, S. A., 1998, In : American Journal of Clinical Pathology. 109, 2, p. 173-180 8 p.

Research output: Contribution to journalArticle

29 Scopus citations
1997

Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer

Leiserowitz, G. S., Russell, A. H., Kinney, W. K., Smith, L. H., Taylor, M. H. & Scudder, S. A., Sep 1997, In : Gynecologic Oncology. 66, 3, p. 509-514 6 p.

Research output: Contribution to journalArticle

43 Scopus citations
1994

Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies

Walker, R., Crebbin, V., Stern, J., Scudder, S. A. & Schwartz, P., 1994, In : Anticancer Research. 14, 5 A, p. 1703-1709 7 p.

Research output: Contribution to journalArticle

8 Scopus citations
1992

Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva

Russell, A. H., Mesic, J. B., Scudder, S. A., Rosenberg, P. J., Smith, L. H., Kinney, W. K., Townsend, D. E., Trelford, J. D., Taylor, M. H., Zukowski, C. L. & McMahon, K. G., 1992, In : Gynecologic Oncology. 47, 1, p. 14-20 7 p.

Research output: Contribution to journalArticle

79 Scopus citations

The integration of computed tomography and magnetic resonance imaging in treatment planning for gynecologic cancer

Russell, A. H., Anderson, M., Walter, J., Kinney, W., Smith, L. H. & Scudder, S. A., 1992, In : Clinical Obstetrics and Gynecology. 35, 1, p. 55-72 18 p.

Research output: Contribution to journalArticle

21 Scopus citations
1991

A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2

Meyers, F. J., Paradise, C., Scudder, S. A., Goodman, G. & Konrad, M., Mar 1991, In : Clinical Pharmacology and Therapeutics. 49, 3, p. 307-313 7 p.

Research output: Contribution to journalArticle

44 Scopus citations
18 Scopus citations
1990

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Garcia, A. A., Hirte, H., Fleming, G., Yang, D., Tsao-Wei, D. D., Roman, L., Groshen, S., Swenson, S., Markland, F., Gandara, D. R., Scudder, S. A., Morgan, R., Chen, H., Lenz, H. J. & Oza, A. M., Sep 15 1990, In : Cancer Research. 50, 18, p. 5919-5924 6 p.

Research output: Contribution to journalArticle

1988

Dna cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells

Scudder, S. A., Brown, J. M. & Sikic, B. I., Oct 19 1988, In : Journal of the National Cancer Institute. 80, 16, p. 1294-1298 5 p.

Research output: Contribution to journalArticle

29 Scopus citations
1986

High-dose megestrol acetate therapy of ovarian carcinoma: A phase II study by the Northern California Oncology Group

Sikic, B. I., Scudder, S. A., Ballon, S. C., Soriero, O. M., Christman, J. E., Suey, L., Ehsan, M. N., Brandt, A. E. & Evans, T. L., 1986, In : Seminars in Oncology. 13, 4 SUPPL. 4, p. 26-32 7 p.

Research output: Contribution to journalArticle

35 Scopus citations